2026 NPPES data Hematology & Oncology Physician NPI 1295742153 MD
Verify on CMS →

Thomas Reid, MD

Hematology & Oncology Physician in Havre, Montana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 189 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
61.2/100
▼ 22 pts below national avg 83.5 · Mid-tier
Industry payments
$1.0K
43 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Thomas Reid, MD reported a CMS MIPS final score of 61.2/100 - below the 83.5 national average - and filed 1,260 Medicare Part D claims in 2024.

61.2/100
MIPS score · -22 vs avg
1K
Part D claims, 2024
83%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Thomas Reid, MD

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1295742153), first enumerated 08/02/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,260 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 61.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $1.0K in reported industry payments (43 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1295742153 · Hematology & Oncology Physician

NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1295742153
  • ENUM-LEGACY 2006
  • TAX-MID 12K Hematology &
  • MIPS-LOW 61.2/100
  • RX-MID 1,260
  • BOOK-THIN 31 in Montana
  • PHOTO-FINISH Amanullah Khan, MD,… · ±0.1

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Thomas Reid, MD's MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

61 ≥ 6th percentile 6% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). This entry sits in this band. 70–80: 94,570 measured providers (21%). Above this entry. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Thomas Reid, MD sits

This provider among hematology & oncology physician peers

Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Thomas Reid, MD writes more Part D claims than 74% of them and scores higher on MIPS quality than 3% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.5Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 68Thomas Reid, MD, Part D claim volume, percentile in specialty: 74 · MIPS quality, percentile: 3
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Thomas Reid, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Thomas Reid, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Thomas Reid, MD?

Below national average

NPI registry status

Active

Issued 08/02/2006

NPI 1295742153

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

1,260 42% vs specialty avg

2024 prescription claims

Specialty avg: 885

MIPS final score

61.2/100 22.3 pts vs avg

Mid-tier band

vs 83.5 national avg

Specialty distribution in Montana

How Hematology & Oncology Physician compares to other specialties among Montana providers

Montana providers
Clinical Social Worker6.4%Physical Therapist6.4%Mental Health Counselor5.1%Pharmacist5%Professional Counselor4.3%Addiction (Substance Use Dis…4.2%Hematology & Oncology Physic…0.1%
Largest specialties in Montana (% of in-state providers)

Medicare quality performance, MIPS

Thomas Reid, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
61.2/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%61.2%
MIPS final score (Hematology & Oncology Physician) - 61.2/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

40 13TH ST W
Havre, MT 59501

Provider Details

NPI 1295742153
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 08/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

61.1748
Final Score
Measured-score avg: 83.5
71.8372
Quality
15.412
Cost
80
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Thomas Reid, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

West Park Hospital District
Cody, WY
William H And Carrie Gottsche Foundation
Thermopolis, WY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Thomas Reid, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.0K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Thomas Reid, MD - brand share 17.0%
Hematology & Oncology Physician average

17% brand-name claims vs 83% generic, on 1,260 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,260
Total Claims
$2.4M
Total Drug Cost
189
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,665.4
Total Day Supply
46,622
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$1.9M
Generic Drug Cost
$472K
Opioid Claims
51 (4.0% rate)
Antibiotic Claims
64

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
2.17
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Thomas Reid, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Anastrozole
90
Prednisone
88
Levothyroxine Sodium
87
Abiraterone Acetate
79
Eliquis
Apixaban
71
Letrozole
65
Acyclovir
49
Famotidine
49
Potassium Chloride
46
Prochlorperazine Maleate
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Thomas Reid, MD fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Thomas Reid, MD's 1,260 claims are above the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Reid, both outside Montana so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (61.2 here).

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Montana

Other clinicians with the same primary specialty enrolled in Montana, drawn from the same CMS NPPES roster as Reid.

One of 31 Hematology & Oncology Physician providers enrolled in Montana, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Thomas Reid, MD's specialty?
Thomas Reid, MD specializes in Hematology & Oncology Physician and practices in Havre, Montana. Credentials: MD.
How much does Thomas Reid, MD prescribe under Medicare Part D?
In 2024, Thomas Reid, MD wrote 1,260 Medicare Part D claims totaling $2.4M in drug costs for 189 beneficiaries.
What is Thomas Reid, MD's Medicare quality score?
Thomas Reid, MD has a CMS MIPS Final Score of 61.2/100 (Quality: 71.8, Cost: 15.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Thomas Reid, MD located?
Thomas Reid, MD is located at 40 13TH ST W, Havre, MT, 59501. Phone: (406) 262-6000.
What is Thomas Reid, MD's NPI number?
Thomas Reid, MD's National Provider Identifier (NPI) is 1295742153, issued on 08/02/2006.
Does Thomas Reid, MD prescribe more brand-name or generic drugs?
Thomas Reid, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $1.9M in brand drug costs.
Does Thomas Reid, MD prescribe opioids?
Yes, Thomas Reid, MD had 51 opioid claims in 2024 with an opioid prescribing rate of 4.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Thomas Reid, MD prescribe most often?
Based on 2024 Medicare Part D data, Thomas Reid, MD's most frequently prescribed drugs include Anastrozole, Prednisone, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Thomas Reid, MD accept Medicare?
Thomas Reid, MD appears in CMS Medicare data with 1,260 Part D claims and 189 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Thomas Reid, MD's credentials?
Thomas Reid, MD's NPI is 1295742153 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.